Can You Take Vivitrol with Liver Disease?
No, Vivitrol (naltrexone extended-release injectable suspension) is contraindicated in patients with acute hepatitis or liver failure due to risks of hepatotoxicity.[1] The drug carries a boxed warning for this, as elevated liver enzymes have occurred in some patients, sometimes leading to liver injury.[2]
How Does Liver Disease Affect Vivitrol Use?
Vivitrol is metabolized by the liver, so moderate to severe hepatic impairment (Child-Pugh B or C) requires caution and dose monitoring. In clinical studies, patients with mild liver issues tolerated it, but data is limited for advanced cases. Doctors may check baseline liver function tests (LFTs) before starting and monitor every 1-3 months.[1][3]
What Do Clinical Studies Show on Liver Safety?
Trials for alcohol and opioid dependence included patients with mild liver enzyme elevations, with no disproportionate hepatotoxicity signals. Post-marketing reports note rare cases of elevated bilirubin or transaminases, resolving after discontinuation. No large-scale studies exist specifically for moderate/severe liver disease.[2][4]
Alternatives for People with Liver Problems
- Oral naltrexone: Similar liver risks, often avoided too.
- Acamprosate (Campral): Safer for liver disease in alcohol dependence; no hepatotoxicity.
- Disulfiram: Risky with liver issues.
- Non-drug options: Behavioral therapy, counseling, or buprenorphine (for opioids, less liver impact).[5]
Consult a doctor for personalized advice, as individual factors like disease stage matter.
Key Warnings and Monitoring
Avoid if you have active liver failure. Symptoms to watch: jaundice, dark urine, fatigue. FDA label advises against use in acute liver disease and close LFT monitoring otherwise.[1]
Sources
[1]: Vivitrol Prescribing Information (FDA)
[2]: Vivitrol Boxed Warning Summary
[3]: LiverTox Database on Naltrexone
[4]: Vivitrol Clinical Pharmacology
[5]: ASAM Guidelines on Alcohol/Opioid Use Disorder